1. Home
  2. BIAF vs XPON Comparison

BIAF vs XPON Comparison

Compare BIAF & XPON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • XPON
  • Stock Information
  • Founded
  • BIAF 2014
  • XPON 2016
  • Country
  • BIAF United States
  • XPON United States
  • Employees
  • BIAF N/A
  • XPON N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • XPON Electronic Components
  • Sector
  • BIAF Health Care
  • XPON Technology
  • Exchange
  • BIAF Nasdaq
  • XPON Nasdaq
  • Market Cap
  • BIAF 7.6M
  • XPON 6.2M
  • IPO Year
  • BIAF 2022
  • XPON 2022
  • Fundamental
  • Price
  • BIAF $3.24
  • XPON $1.48
  • Analyst Decision
  • BIAF Hold
  • XPON
  • Analyst Count
  • BIAF 1
  • XPON 0
  • Target Price
  • BIAF N/A
  • XPON N/A
  • AVG Volume (30 Days)
  • BIAF 7.6M
  • XPON 3.0M
  • Earning Date
  • BIAF 11-13-2025
  • XPON 11-13-2025
  • Dividend Yield
  • BIAF N/A
  • XPON N/A
  • EPS Growth
  • BIAF N/A
  • XPON N/A
  • EPS
  • BIAF N/A
  • XPON N/A
  • Revenue
  • BIAF $7,681,059.00
  • XPON $8,414,250.00
  • Revenue This Year
  • BIAF N/A
  • XPON $61.26
  • Revenue Next Year
  • BIAF $20.04
  • XPON N/A
  • P/E Ratio
  • BIAF N/A
  • XPON N/A
  • Revenue Growth
  • BIAF 4.99
  • XPON 68.33
  • 52 Week Low
  • BIAF $2.34
  • XPON $0.60
  • 52 Week High
  • BIAF $67.12
  • XPON $5.50
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 53.34
  • XPON 50.36
  • Support Level
  • BIAF $2.36
  • XPON $1.36
  • Resistance Level
  • BIAF $7.29
  • XPON $1.80
  • Average True Range (ATR)
  • BIAF 0.63
  • XPON 0.17
  • MACD
  • BIAF -0.30
  • XPON 0.00
  • Stochastic Oscillator
  • BIAF 23.73
  • XPON 29.88

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About XPON Expion360 Inc.

Expion360 Inc is focused on the design, assembly, manufacturing, and sales of lithium iron phosphate (LiFePO4) batteries and supporting accessories for recreational vehicles (RV's) and marine applications with plans to expand into home energy storage products and industrial applications. Its product offerings include some of the minimal-footprint batteries in the RV & Marine industry.

Share on Social Networks: